Dicot Pharma AB (STO:DICOT)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2542
+0.0148 (6.18%)
At close: Sep 3, 2026

Dicot Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-67.82-82.62-59.28-45.03-31.8-27.25
Net Income
-66.24-80.24-57.7-44.16-31.76-27.17
Earnings Per Share
-0.03-0.04-0.05-0.08-0.26-0.42
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
248.469.19113.4247.349.3830.33
Net Cash Growth
134.78%-39.00%139.58%404.88%-69.08%49.20%
Net Cash Per Share
0.120.040.100.090.080.47
Cash & Investments
248.469.19113.4247.349.3830.33

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-72.15-85.85-58.87-45.23-29.71-25.87
Capital Expenditures
------
Free Cash Flow
-72.15-85.85-58.87-45.23-29.71-25.87
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------